BOSE PUBLIC AFFAIRS GROUP

Lobbying for ASSOCIATION FOR PRESCRIPTION PSYCHEDELICS · Industry association representing pharmaceutical companies

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $30,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

FDA approval and regulation of prescription psychedelic therapies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.